FocusCANCER IMMUNOLOGY

Developing combination immunotherapies against cancer that make sense

See allHide authors and affiliations

Science Immunology  02 Nov 2018:
Vol. 3, Issue 29, eaav1872
DOI: 10.1126/sciimmunol.aav1872

Article Information

vol. 3 no. 29

PubMed: 
Published By: 
History: 
  • Received September 19, 2018
  • Accepted October 4, 2018
  • .

Author Information

  1. André Veillette1,2,3,* and
  2. Dominique Davidson1
  1. 1Laboratory of Molecular Oncology, Institut de Recherches Cliniques de Montréal (IRCM), Montréal, Québec H2W1R7, Canada.
  2. 2Department of Medicine, University of Montréal, Montréal, Québec H3C3J7, Canada.
  3. 3Department of Medicine, McGill University, Montréal, Québec H3G 1Y6, Canada.
  1. *Corresponding author. Email: andre.veillette{at}ircm.qc.ca

Altmetric

Article usage

Article usage: October 2018 to May 2021

AbstractFullPdf
Oct 2018021
Nov 2018234048271465
Dec 2018104014265
Jan 20191884526
Feb 2019126209
Mar 2019922214
Apr 2019902410
May 201986165
Jun 201954136
Jul 201942206
Aug 201954134
Sep 2019621411
Oct 201912193
Nov 20199353
Dec 20195563
Jan 202082192
Feb 20203632
Mar 20203975
Apr 20206792
May 20205998
Jun 20204794
Jul 20203283
Aug 20206161
Sep 202041122
Oct 202037140
Nov 20203065
Dec 202037193
Jan 20213492
Feb 20212930
Mar 20215387
Apr 20213961
May 20212073

Stay Connected to Science Immunology